Resolutions from the Extraordinary Shareholders’ Meeting 2024
04 mars 2024 11h06 HE
|
Novozymes A/S
Company Announcement no. 10 March 4, 2024Today an extraordinary shareholders’ meeting was conducted. The following resolutions were made: Adoption of Novonesis A/S as secondary name and...
Invitation to an extraordinary shareholders’ meeting of Novozymes A/S
09 févr. 2024 04h00 HE
|
Novozymes A/S
An extraordinary shareholders’ meeting of Novozymes A/S will be held on Monday March 4, 2024 at 4:00 pm CET at Boege Alle 10-12, 2970 Hoersholm, Denmark.
Attachments
...
The Novozymes Report 2023
08 févr. 2024 13h52 HE
|
Novozymes A/S
This annual report has been released subsequent to the approval of the combination of Novozymes and Chr. Hansen on January 29, 2024. The new combined group is called Novonesis. As an annual...
Trading by management and close relations of management
02 févr. 2024 08h13 HE
|
Novozymes A/S
Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and...
Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed
02 févr. 2024 02h28 HE
|
Novozymes A/S
Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024Company announcement No. 07 On January 29, 2024, following the satisfaction of...
Legacy Novozymes delivers solid last full-year results
01 févr. 2024 02h00 HE
|
Novozymes A/S
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks...
Results update for 2023 – unaudited
01 févr. 2024 01h59 HE
|
Novozymes A/S
6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual...
Total number of voting rights and capital on January 31, 2024
31 janv. 2024 08h20 HE
|
Novozymes A/S
Total number of voting rights and capital on January 31, 2024 January 31, 2024Company announcement No. 05 Referring to company announcement 02, on January 29, 2024, where Novozymes A/S...
Trading by management and close relations of management
29 janv. 2024 09h59 HE
|
Novozymes A/S
January 29, 2024Company announcement No. 04 Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...
Major shareholder announcement
29 janv. 2024 07h13 HE
|
Novozymes A/S
Major shareholder announcement January 29, 2024Company announcement No. 03 On January 29, 2024, following the satisfaction of all conditions precedent, the combination of...